Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

clarkhealthcommunications

- PMLiVE

Trial of AbbVie’s Rova-T disappoints at ASCO

But company says the modest trial data is “a good early sign” for lung cancer drug

- PMLiVE

Anke Buchta joins emotive

She becomes the agency’s creative director

- PMLiVE

DiCE Molecules adds Dr Richard Scheller to its board of directors

He currently serves as chief scientific officer at 23andMe

- PMLiVE

Explosive evolution

Companies are being forced to diversify and specialise their business models

- PMLiVE

AstraZeneca to develop Lynparza companion diagnostic

Will collaborate with Foundation Medicine on test for its ovarian cancer drug

- PMLiVE

Biosimilar trastuzumab comparable to brand, ASCO hears

Roche’s Herceptin matched in safety and efficacy by Mylan and Biocon’s breast cancer drug

Roche Basel Switzerland

Roche’s Tecentriq works as first-line bladder cancer therapy

New trial data presented at ASCO supports wider use of the drug

Takeda appoints chief financial officer and corporate officer

James Kehoe takes on both roles from 15 June

- PMLiVE

OPKO appoints vice president of medical affairs

Dr Douglass Laidlaw brings experience from Relypsa and Sanofi

Aiming high for women

The UN's Sustainable Development Goals and the need to also make gradual improvements

Creating a better new-to-brand patient experience

By Robert MacMillan, VP of EHR and Innovation

Aptus Health

Shire Basingstoke

Shire completes $32bn Baxalta merger

Creates world leading rare diseases specialist

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links